<SEC-DOCUMENT>0001654954-18-002717-index.html : 20180316
<SEC-HEADER>0001654954-18-002717.hdr.sgml : 20180316
<ACCEPTANCE-DATETIME>20180316171420
ACCESSION NUMBER:		0001654954-18-002717
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20171116
FILED AS OF DATE:		20180316
DATE AS OF CHANGE:		20180316

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Cross Shawn
		CENTRAL INDEX KEY:			0001734779

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08092
		FILM NUMBER:		18696606

	MAIL ADDRESS:	
		STREET 1:		1825 K STREET SUITE 510
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20006

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GT Biopharma, Inc.
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1825 K STREET
		STREET 2:		SUITE 510
		CITY:			WASHINGTON, D.C.
		STATE:			DC
		ZIP:			33602
		BUSINESS PHONE:		(800) 304-9888

	MAIL ADDRESS:	
		STREET 1:		1825 K STREET
		STREET 2:		SUITE 510
		CITY:			WASHINGTON, D.C.
		STATE:			DC
		ZIP:			33602

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19940916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>section16.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: section16.html

Document 1 - RAW XML: section16.xml

</DOCUMENT>
</SEC-DOCUMENT>